aod9604 human clinical trials weight loss results efficacy Fat Burner - Peptides for Visceral Fat & Metabolism AOD-9604: Lessons from a discontinued

Phase 1: Activation (Weeks 14) Dose: Daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases

5 ResearchGate (2021)Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice

This approach mirrors how anti-obesity medications are used in clinical practice, where long-term maintenance therapy prevents weight regain

Some users report initial fatigue or drowsiness as the body adapts to metabolic changes

Here is what nobody told you